Ads
related to: who owns pfizer and moderna vaccines similar
Search results
Results From The WOW.Com Content Network
But the court ruled another similar patent was valid and that Pfizer and BioNTech's Comirnaty vaccine had infringed it, meaning Moderna is entitled to damages in relation to sales after March 2022.
More specifically, Pfizer's and Moderna’s COVID vaccines target the KP.2 variant — the more recent variant circulating this past summer — while Novavax targets the JN.1 variant (the parent ...
Number of employees. 5,600 (2023) Website. modernatx.com. Footnotes / references[ 1 ][ 2 ][ 3 ] Moderna, Inc. (/ məˈdɜːrnə / mə-DUR-nə) [ 4 ] is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2][33] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials, logistics, and manufacturing. [45][46] It is authorized for use ...
The Moderna news followed preliminary results from the Pfizer-BioNTech vaccine candidate, BNT162b2, with Moderna demonstrating similar efficacy, but requiring storage at the temperature of a standard medical refrigerator of 2–8 °C (36–46 °F) for up to thirty days or −20 °C (−4 °F) for up to four months, whereas the Pfizer-BioNTech ...
All new Pfizer and Moderna vaccines target the Omicron variant KP.2 strain of SARS-CoV-2, the virus that causes COVID. Spikevax, the COVID-19 vaccine manufactured by Moderna and FDA-approved for ...
On Aug. 22, the Food and Drug Administration (FDA) approved the updated mRNA vaccines developed by pharmaceutical companies Moderna and Pfizer-BioNTech for people 12 years and older and granted ...
2011–. Spouse. Brenda Bancel. Children. 2. Stéphane Bancel (born 20 July 1972) [1] is a French business executive. He is the chief executive officer (CEO) of the American pharmaceutical and biotechnology company Moderna, known for its COVID-19 vaccine. Before joining Moderna, Bancel was the CEO of French diagnostics company BioMérieux.